4-HO-DET Facts
Psychedelic;
Description
4-HO-DET (4-hydroxy-N,N-diethyltryptamine) — also known as CZ-74 — is a synthetic psychedelic of the tryptamine class. It activates serotonin receptors in the brain, producing the visual and cognitive shifts characteristic of classical psychedelics.
Subjective effects include geometric visual patterns, emotional intensification, time alteration, and shifts in thought.[1] The experience is close to psilocin — warm, moderately paced, and emotionally saturating — with reports of a slightly lighter physical sensation.[2]
4-HO-DET does not produce physical dependence, and rapid tolerance limits compulsive use.[3][4] The primary risks are psychological — panic, paranoia, and psychosis in predisposed individuals — and combining it with MAOIs or tramadol risks dangerous overheating and seizures.
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 4 – 6 hoursAfter-effects 2 – 6 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- psilocybin;
psilocin; LSD; mescaline; DMT; 4-AcO-DMT; 4-HO-MET; 4-AcO-DET
Effectslikely at a common dose
- Perception
- Color enhancement;
Visual drifting; Color alteration; Depth perception distortion; Perspective distortion; Symmetrical texture repetition; Music enhancement; Tracers; Brightness alteration; Geometry; Holotropic state; Visual breathing; +23 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion - Body
- Spontaneous body sensations;
Pupil dilation; Body high; Body scan awareness; +28 possible, including Temperature dysregulation, Muscle tension, Dizziness - Thinking
- Pattern recognition enhancement;
Conceptual thinking; Immersion enhancement; Novelty enhancement; Thought connectivity; Aesthetic enhancement; Cognitive euphoria; Cognitive flexibility; Introspection enhancement; Openness enhancement; +20 possible, including Memory suppression, Thought loops, Cognitive impairment - Feeling
- Emotional enhancement;
Emotional lability; Euphoria; +6 possible, including Anxiety, Dysphoria, Paranoia - Self
- Emotional susceptibility;
+8 possible, including Derealization, Depersonalization - Time
- Time alteration;
Present-moment absorption; +1 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 4 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011) Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice — Journal of Psychopharmacology doi:10.1177/0269881110388326
- [2]^Gatch MB, Hoch A, Carbonaro TM (2021) Discriminative Stimulus Effects of Substituted Tryptamines in Rats — ACS Pharmacology & Translational Science doi:10.1021/acsptsci.0c00173
- [3]^de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonzalez-Maeso J (2022) Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.2c00170
- [4]^Nichols DE (2018) Chemistry and Structure-Activity Relationships of Psychedelics. — Current Topics in Behavioral Neurosciences doi:10.1007/7854_2017_475